Annals of SBV

Register      Login

VOLUME 4 , ISSUE 2 ( July-Dec, 2015 ) > List of Articles

Tuberculosis: Implications for Anaesthesia

Dr. Prof Vishwanath R Hiremath, Dr. Pranjali Kurhekar, Dr. Dilip Kumar, Dr. T Krishna Prasad.

Keywords : Tuberculosis, Anaesthesia, Nosocomial Infection, Transmission, Drug resistant

Citation Information : Hiremath DP, Kurhekar DP, Kumar DD, Prasad. DT. Tuberculosis: Implications for Anaesthesia. 2015; 4 (2):33-37.

DOI: 10.5005/jp-journals-10085-4210

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2015; The Author(s).


Tuberculosis (TB) remains one of the major occupational risk hazards for anaesthesiologist and health care workers in operation rooms in some of the developing countries. Anaesthesiologists do come across providing anaesthesia for patients with active tuberculosis or problems unrelated to tuberculosis like trauma and for various surgeries. As per the World Health Organization (WHO) reporting in 2013, 9 million new cases are supposed to be suffering from TB; among this 2-3% cases are found to be drug resistant. It is true that effective infection control measures and the availability of effective antibiotics for mycobacterium tuberculosis have decreased the risk of nosocomial infection. However, anaesthesiologist and the health workers in the developing countries are still at the risk of tuberculosis transmission from the patients when compared to their counterparts in the developed countries; due to the lack of adequate resources to prevent nosocomial transmission of tuberculosis. Hence, the special precautions need to be under taken by the anaesthesiologist while providing anaesthesia to these patients. From the patient point of view various drug interactions, side effects of anti-tuberculosis drugs needs to be considered preoperatively along with necessary investigations. Immune compromised patients with co infected HIV have a higher risk of developing tuberculosis.

PDF Share
  1. National strategic plan for HIV and AIDS, STIS and TB, 2012-2016.
  2. Floyd K, Baddeley A, Dias HM, et al. The sixteenth global report of tuberculosis. World Health Organization [homepage on the Internet]. 2011. c2012. Available from:
  3. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. [Cochrane review] In: The Cochrane Library, Issue 1; 2010.
  4. Chandra A, Barsavalikar JN, Bhatnagar A. Tuberculosis and Anaesthesia. Journal of Indian Medical Asso 2013;111(3):178-180.
  5. Teo DJ, Lim JW. Transmission of tuberculosis from patient to healthcare workersin anaesthesia context. Ann Acad Med Singapore 2004;33(1)95-9.
  6. Knechel NA. Tuberculosis: pathophysiology, clinical features, and diagnosis. Crit Care Nurse. 2009;29(2):34-43.
  7. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161(4 Pt 2): 221-242.
  8. Moore DP, Schaaf HS, Nuttall J, Marais BJ. Childhood tuberculosis guidelines of the Southern African Society for Paediatric Infectious Diseases. South Afr J Epidemiol Infect. 2009;24(3):57-68.
  9. Small PM, Maddhykar P. Tuberculosis diagnosis: time for a game change. Clin Pharmacol Ther. 2010;363(11):1070-1071.
  10. Menon PR. A prospective assessment of the role of bronchoscpoly and bronchoalveolar lavage in evaluation of children with pulmonary tuberculosis. J Trop Pediatr. 2011;57(5):363-367.
  11. Lalvani A, Pareek M. A 100-year update on diagnosis of tuberculosis infection. Br Med Bull. 2010;93:69-84.
  12. Swart A, Harris V. Drug interactions with tuberculosis therapy. The South African Journal of Continuing Medical Education. 2005; 23(2):56-60.
  13. Sweeney P, Bromilow J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia. 2006;61(2):159-177.
  14. Fromm MF, Eckhardt K, Schanzle G, et al. Loss of analgesic effect of morphine due to coadministration of rifampicin. Pain. 1997;7291):261-267.
  15. Backman B, Olkkola KT, Neuvonen PJ. Rifampin drastically reduces plasma concentrations and effects of oral midazolam. Clin Pharmacol Ther. 1996; 59(1):7-13.
  16. Tait AR. Occupational transmission of tuberculosis: implications for the anesthesiologist. Anesth Analg. 1997;85(2):444-451.
  17. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. Centers for Disease Control and Prevention. 2005. c2012. Available from: http://www.
  18. Langevin PB, Rand RH, Layon AJ. The potential for dissemination of Mycobacterium tuberculosis through the anesthesia breathing circuit. Chest. 1999;115(4):1107-1114.
  19. Lee HP, Wang de Y. Objective assessment if increase in breathing resisrance of N95 respirators on human subjects. Ann Occup Hyg. 2011;55(8):917-921.
  20. National Institute for Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE [homepage on the Internet]. 2011. c2012. Available from: www.nice.
  21. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161(4 Pt 2):221-224.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.